Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 2Colorectal Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms 1Mouth Neoplasms 1Melanoma 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma in Situ 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Radiotherapy 8Cisplatin 8Cetuximab 8pembrolizumab 5Fluorouracil 5Drug Therapy 5Surveys and Questionnaires 4Celecoxib 4Radiotherapy, Intensity-Modulated 3Radiation 3Sentinel Lymph Node Biopsy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Physical Therapy Modalities 2Nicotine 2Interviews as Topic 2Injections 2Immunohistochemistry 2High-Energy Shock Waves 2Counseling 2Chemoradiotherapy 2Bupropion 2Aminolevulinic Acid 2trametinib 1traY protein, E coli 1toripalimab 1sodium thiosulfate 1sargramostim 1motexafin gadolinium 1mogamulizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mouth Neoplasms × Indomethacin × Clear all
NCT00210470 2020-12-11

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Brooklyn ImmunoTherapeutics, LLC

Phase 2 Completed
27 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡